Enhancing cognitive behavioral therapy: Is the finish line in sight?
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 28251909.
- Also identified by DOI 10.1126/scitranslmed.aam9857.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Augmentation of cognitive behavioral therapy with D-cycloserine (DCS) for anxiety disorders results in a small decrease in symptom severity.
Medical subject headings
- Obsessive-Compulsive Disorder
- Stress Disorders, Post-Traumatic